Oxidation-Specific Biomarkers and Risk of Peripheral Artery Disease

被引：66

作者：

Bertoia, Monica L. ^{[1
,2
]}

Pai, Jennifer K. ^{[3
,4
]}

Lee, Jun-Hee ^{[5
,6
]}

Taleb, Adam ^{[5
]}

Joosten, Michel M. ^{[1
,2
,7
,8
]}

Mittleman, Murray A. ^{[1
,3
]}

Yang, Xiaohong ^{[5
]}

Witztum, Joseph L. ^{[5
]}

Rimm, Eric B. ^{[2
,3
,4
]}

Tsimikas, Sotirios ^{[5
]}

Mukamal, Kenneth J. ^{[1
,2
]}

机构：

[1] Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA

[2] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA

[3] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA

[4] Harvard Univ, Brigham & Womens Hosp, Channing Div Network Med, Dept Med,Med Sch, Boston, MA 02115 USA

[5] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA

[6] Hallym Univ, Div Cardiol, Kang Dong Sacred Heart Hosp, Med Ctr, Seoul, South Korea

[7] Top Inst Food & Nutr, Wageningen, Netherlands

[8] Univ Groningen, Univ Med Ctr Groningen, Dept Internal Med, Groningen, Netherlands

来源：

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2013年 / 61卷 / 21期

基金：

美国国家卫生研究院;

关键词：

autoantibodies; biomarker; immune complex; lipoprotein (a); oxidized phospholipids; peripheral artery disease; LOW-DENSITY-LIPOPROTEIN; PHYSICAL-ACTIVITY QUESTIONNAIRE; ACUTE CORONARY SYNDROMES; OXIDIZED PHOSPHOLIPIDS; VASCULAR-DISEASE; CARDIOVASCULAR OUTCOMES; MYOCARDIAL-INFARCTION; APOLIPOPROTEIN B-100; IMMUNE-COMPLEXES; HEART-DISEASE;

D O I：

10.1016/j.jacc.2013.02.047

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Objectives The goal of this study was to examine the prospective association between oxidation-specific biomarkers, primarily oxidized phospholipids (OxPL) on apolipoprotein B-100-containing lipoproteins (OxPL/apoB) and lipoprotein (a) [Lp(a)], and risk of peripheral artery disease (PAD). We examined, as secondary analyses, indirect measures of oxidized lipoproteins, including autoantibodies to malondialdehyde-modified low-density lipoprotein (MDA-LDL) and apolipoprotein B-100 immune complexes (ApoB-IC). Background Biomarkers to predict the development of PAD are lacking. OxPL circulate in plasma, are transported by Lp(a), and deposit in the vascular wall and induce local inflammation. Methods The study population included 2 parallel nested case-control studies of 143 men within the Health Professionals Follow-up Study (1994 to 2008) and 144 women within the Nurses' Health Study (1990 to 2010) with incident confirmed cases of clinically significant PAD, matched 1: 3 to control subjects. Results Levels of OxPL/apoB were positively associated with risk of PAD in men and women: pooled relative risk: 1.37, 95% confidence interval: 1.19 to 1.58 for each 1-SD increase after adjusting age, smoking, fasting status, month of blood draw, lipids, body mass index, and other cardiovascular disease risk factors. Lp(a) was similarly associated with risk of PAD (pooled adjusted relative risk: 1.36; 95% confidence interval: 1.18 to 1.57 for each 1-SD increase). Autoantibodies to MDA-LDL and ApoB-IC were not consistently associated with risk of PAD. Conclusions OxPL/apoB were positively associated with risk of PAD in men and women. The major lipoprotein carrier of OxPL, Lp(a), was also associated with risk of PAD, reinforcing the key role of OxPL in the pathophysiology of atherosclerosis mediated by Lp(a). (C) 2013 by the American College of Cardiology Foundation

引用

页码：2169 / 2179

页数：11

共 50 条

[11] Lipoprotein(a): more interesting than ever after 50 years [J].

Dube, Joseph B. ;

Boffa, Michael B. ;

Hegele, Robert A. ;

Koschinsky, Marlys L. .

CURRENT OPINION IN LIPIDOLOGY, 2012, 23 (02) :133-140

[12] Autoantibodies against oxidized low-density lipoprotein and cardiolipin in patients with coronary heart disease [J].

Erkkilä, AT ;

Närvänen, O ;

Lehto, S ;

Uusitupa, MIJ ;

Ylä-Herttuala, S .

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2000, 20 (01) :204-209

[13]

Erqou S, 2009, JAMA-J AM MED ASSOC, V302, P412, DOI 10.1001/jama.2009.1063

[14] Lipoprotein(a) and Risk of Coronary, Cerebrovascular, and Peripheral Artery Disease The EPIC-Norfolk Prospective Population Study [J].

Gurdasani, Deepti ;

Sjouke, Barbara ;

Tsimikas, Sotirios ;

Hovingh, G. Kees ;

Luben, Robert N. ;

Wainwright, Nicholas W. J. ;

Pomilla, Cristina ;

Wareham, Nicholas J. ;

Khaw, Kay-Tee ;

Boekholdt, S. Matthijs ;

Sandhu, Manjinder S. .

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2012, 32 (12) :3058-3065

[15]

Hirsch AT, 2006, CIRCULATION, V113, pE463, DOI 10.1161/CIRCULATIONAHA.106.174526

[16] Antibodies to oxidized LDL in relation to intima-media thickness in carotid and femoral arteries in 58-year-old subjectively clinically healthy men [J].

Hulthe, J ;

Bokemark, L ;

Fagerberg, B .

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2001, 21 (01) :101-107

[17] Novel cardiovascular risk factors do not completely explain the higher prevalence of peripheral arterial disease among African Americans [J].

Ix, Joachim H. ;

Allison, Matthew A. ;

Denenberg, Julie O. ;

Cushman, Mary ;

Criqui, Michael H. .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 51 (24) :2347-2354

[18] Plasma lipoprotein(a) indicates risk for 4 distinct forms of vascular disease [J].

Jones, Gregory T. ;

van Rij, Andre M. ;

Cole, Jennifer ;

Williams, Michael J. A. ;

Bateman, Emma H. ;

Marcovina, Santica M. ;

Deng, Metying ;

McCormick, Sally P. A. .

CLINICAL CHEMISTRY, 2007, 53 (04) :679-685

[19] Associations Between Conventional Cardiovascular Risk Factors and Risk of Peripheral Artery Disease in Men [J].

Joosten, Michel M. ;

Pai, Jennifer K. ;

Bertoia, Monica L. ;

Rimm, Eric B. ;

Spiegelman, Donna ;

Mittleman, Murray A. ;

Mukamal, Kenneth J. .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2012, 308 (16) :1660-1667

[20] Immunoglobulin M type of autoantibodies to oxidized low-density lipoprotein has an inverse relation to carotid artery atherosclerosis [J].

Karvonen, J ;

Päivänsalo, M ;

Kesäniemi, YA ;

Hörkkö, S .

CIRCULATION, 2003, 108 (17) :2107-2112

← 1 2 3 4 5 →